Richard Geoffrey Vile, PhD

Professor, Rochester, MN, Molecular Medicine

EmailVile.Richard@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Richard Geoffrey Vile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Not started
7 Finished

Research Training Program in Neuro-Oncology
O'Neill, B. P. & Vile, R. G.
Project: Research project
Core A: Administrative Core
Gores, G. J., Vile, R. G., Leof, E. B., Roberts, L. R. & Roberts, L. R.
Project: Research project
Enhancing Therapy of Primary and Recurrent Tumors With Systemic Oncolytic Virus
Vile, R. G. & Kinney, L.
5/7/14 → 4/30/19
Project: Research project
Enhancing Systemic Delivery of Oncolytic Viruses for Cancer Therapy
Vile, R. G. & Kinney, L.
1/1/09 → 11/30/14
Project: Research project
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
Vile, R. G. & Kinney, L.
7/1/08 → 5/31/14
Project: Research project

13714 Citations
68 Scopus h-Index
226 Article
41 Review article
16 Comment/debate
4 Editorial
More

Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma
Monie, D. D., Bhandarkar, A. R., Parney, I. F., Correia, C., Sarkaria, J. N., Vile, R. G. & Li, H., Feb 2021, In: Neurosurgical focus. 50, 2, p. 1-11 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors
Wongthida, P., Schuelke, M. R., Driscoll, C. B., Kottke, T., Thompson, J. M., Tonne, J., Stone, C., Huff, A. L., Wetmore, C., Davies, J. A., Parker, A. L., Evgin, L. & Vile, R. G., Dec 1 2020, In: Neuro-oncology. 22, 12, p. 1757-1770 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
Driscoll, C. B., Schuelke, M. R., Kottke, T., Thompson, J. M., Wongthida, P., Tonne, J. M., Huff, A. L., Miller, A., Shim, K. G., Molan, A., Wetmore, C., Selby, P., Samson, A., Harrington, K., Pandha, H., Melcher, A., Pulido, J. S., Harris, R., Evgin, L. & Vile, R. G., Dec 1 2020, In: Nature communications. 11, 1, 790.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators
Ayasoufi, K., Pfaller, C. K., Evgin, L., Khadka, R. H., Tritz, Z. P., Goddery, E. N., Fain, C. E., Yokanovich, L. T., Himes, B. T., Jin, F., Zheng, J., Schuelke, M. R., Hansen, M. J., Tung, W., Parney, I. F., Pease, L. R., Vile, R. G. & Johnson, A. J., Dec 1 2020, In: Brain. 143, 12, p. 3629-3652 24 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Crespo-Rodriguez, E., Bergerhoff, K., Bozhanova, G., Foo, S., Patin, E. C., Whittock, H., Buus, R., Haider, S., Muirhead, G., Thway, K., Newbold, K., Coffin, R. S., Vile, R. G., Kim, D., McLaughlin, M., Melcher, A. A., Harrington, K. J. & Pedersen, M., Aug 5 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 698.
Research output: Contribution to journal › Article › peer-review

Open Access